Akeso (9926.HK) announced that its first-in-class bispecific antibody, ivonescimab (PD-1/VEGF bispecific antibody), in combination with chemotherapy for first-line treatment of triple-negative ...
The Fructo-Oligosaccharides market is on a dynamic growth trajectory, with global demand expected to rise from USD 3.07 billion in 2025 to USD 5.88 billion by 2035, at a CAGR of 6.7%. Fueled by rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback